Long-Term Safety and Effectiveness of Style 410 Highly Cohesive Silicone Breast Implants

Abstract

Background

In 2006, a single-center Swedish study demonstrated a low rupture rate and high patient satisfaction with the Style 410 shaped, form-stable gel implant. The current study aimed to validate the accuracy of the previously published results across multiple European sites.

Methods

A total of 163 subjects (~70% had augmentation [n = 112], 15% had reconstruction [n = 25], and 15% had revision [n = 26]) underwent a physical examination followed by breast magnetic resonance imaging (MRI) for rupture detection. These subjects had been implanted for 5 to 11 years with at least one Style 410 shaped gel breast implant before examination. The secondary end points included lactation, reproductive and breast disease history before and after implantation, and quality-of-life measurements and complications after implantation.

Results

The implant rupture rate was 1.7% a median of 8 years after implantation. Capsular contracture was the most common complication noted at the physical examination, occurring for 5.3% of implants, and there were no cases of grade 4 capsular contracture. The postimplantation rates for lactation and reproductive problems and breast disease were lower than the preimplantation rates. Breast implantation surgery was considered advantageous by 91% of the subjects, demonstrating high patient satisfaction.

Conclusions

The Style 410 anatomically shaped, form-stable gel breast implants demonstrated long-term safety and effectiveness.

The long-term safety and effectiveness of Style 410 shaped gel breast implants (Allergan, Santa Barbara, CA, USA) were previously studied by Hedén et al. [1] at Akademikliniken Hospital in Sweden. This was the first trial to use magnetic resonance imaging (MRI) rupture detection for Style 410 implants 5 or more years after implantation. Notably, the findings showed that the MRI rupture signs for these highly cohesive gel implants were the same as those for standard gel implants. Although that single-center study demonstrated a low rupture rate and high patient satisfaction with the Style 410 implant, the study needed to be validated further across multiple sites to confirm the accuracy of the results. The current study is similar in design to the Hedén trial but expands the subject cohort to include seven sites across Europe.

Subjects and Methods

Study Design

The multicenter study was conducted in six European countries (Sweden, Switzerland, Belgium, Denmark, Finland, and The Netherlands [2 sites]) to investigate the safety and effectiveness of Style 410 implants 5 to 11 years after implantation. A total of 163 subjects (~70% had augmentation [n = 112], 15% had reconstruction [n = 25], and 15% had revision [n = 26]) underwent a physical examination followed by a breast MRI between August 2005 and December 2007.

The seven investigational sites were selected on the basis of professional training and experience in aesthetic and reconstructive surgery, prior experience conducting clinical studies, and history of implanting the devices being studied. Informed consent was obtained from all the subjects, and ethics committees provided oversight.

The data collected at the physical examination included certain local complications; the subjects’ histories of lactation, reproduction, and breast disease; and the investigator’s assessment of rupture status. The subjects completed a quality-of-life questionnaire to assess changes in their lives due to the breast implantation surgery.

All MRIs were performed “closed” with the use of a bilateral dedicated breast coil with unilateral and bilateral switch positions. The local MRI facility was blinded to the Investigator’s clinical judgment of whether the implants were ruptured. The MRI facility forwarded the MRI images on films or disk to the Investigator, who in turn forwarded the images to the MRI Central Reviewer in the United States, a radiologist with extensive experience interpreting MRIs of Style 410 implants.

The Central Reviewer examined all the images to determine rupture. One of four possible outcomes was assigned to each image: 1 (no evidence of rupture), 2 (evidence of rupture), 3 (indeterminate outcome), and 4 (unreadable image). A rupture diagnosis was made when clear evidence on the images showed the linguini sign, subcapsular line, or inverted loop. The absence of these signs resulted in a diagnosis of no rupture. An indeterminate finding signified an image suggestive of rupture but not definitive.

Subjects

The subjects were required to be women who had undergone implantation with an Allergan Style 410 shaped gel breast implant between the years 1995 and 2001 and retained at least one original implant. The subjects also had to be willing and eligible to undergo an MRI scan (e.g., no implanted metal or metal devices, no current pregnancy or breastfeeding, and no history of severe claustrophobia).

Based on the indication for implantation, the subjects were classified into one of three cohorts as follows: augmentation (subject dissatisfaction with breast size or shape, asymmetry, ptosis, or aplasia), reconstruction (mastectomy for cancer or trauma, prophylactic mastectomy, or contralateral asymmetry of the nonreconstructed breast), or revision (previous augmentation or reconstruction with silicone- or saline-filled breast implants).

Devices

The Style 410 implants have an anatomic shape similar to the natural breast shape compared with the round shape of standard implants. They are filled with a highly cohesive gel to create a form-stable device that provides a long-lasting result in vivo [1]. Biocell texturing on the implant shell promotes tissue adherence to reduce implant rotation and capsular contracture [2]. Style 410 implants are available in a wide range of shapes (a matrix involving 12 combinations of implant height and projection ratios that extend across a range of base widths), enabling the physician to select an implant appropriate to each patient’s needs.

Statistical Analyses

All eligible subjects and implants were pooled to form one cohort for analysis. The primary end point was the prevalence of rupture according to MRI results. Secondary analyses of MRI rupture findings were stratified by years of implantation, with implant age rounded to the nearest year. Implant age (time elapsed in vivo) was calculated as the time from the date of implantation until the date of a subject’s MRI procedure.

Descriptive statistics tabulated the frequency of local complications after implantation, pre- and postimplantation lactation and reproduction problems, and the occurrence of breast disease. Quality-of-life questions concerning general and specific changes in subjects’ lives due to breast implantation surgery were rated on a 7-point scale and then categorized with the responses of “much,” “quite,” and “a bit” grouped together to show the percentage of subjects improved, unchanged, or worsened after implantation.

Results

Subject and Surgical Characteristics

The demographic data showed that most of the subjects were white and married (Table 1), with a median age of 43 years (range, 25–83 years). The majority of the 163 subjects received implants for cosmetic augmentation (n = 112), although reconstruction (n = 25) and revision (n = 26) subjects also were represented. Most of the subjects underwent MRI screening on the same day as the physical exam, with a median time of 0 days (range, 0–63 days) elapsed between exam and MRI.

Table 1.

Demographic characteristics (n = 163 subjects)

Characteristic	n	%
Age at implantation (years)
18–19	0	0
20–29	10	6.1
30–39	43	26.4
40–49	58	35.6
50–59	32	19.6
60–69	18	11.0
70+	2	1.2
Race
Caucasian	160	98.2
Black/African	1	0.6
Asian	1	0.6
Hispanic	0	0
Other	1	0.6
Marital status
Single	36	22.1
Married	96	58.9
Widowed	9	5.5
Separated	7	4.3
Divorced	14	8.6
No answer	1	0.6
Education
Primary/secondary school	22	13.5
High school	89	54.6
College	52	31.9

The majority of the 300 devices were placed in a subglandular position using an inframammary incision site (Table 2). The most commonly used implant was full-height moderate projection. The most popular of these implants was the 270-g size. The median implant age at MRI was 8 years (range, 5–11 years).

Table 2.

Surgical and device characteristics (n = 300 implants)

Characteristic	n	%
Implant placement
Subglandular	177	59.0
Submuscular	121	40.3
Unknown	2	0.7
Incision site
Periareolar	22	7.3
Inframammary	242	80.7
Mastectomy scar	29	9.7
Axillary	2	0.7
Breast scar	3	1.0
Other	4	1.3
Product style
Full height/full projection (FF)	5	1.7
Full height/moderate projection (FM)	132	44.0
Moderate height/moderate projection (MM)	54	18.0
Low height/full projection (LF)	1	0.3
Unknown	108	36.0
Implant age at MRI scan (years)
5	13	4.3
6	52	17.3
7	58	19.3
8	47	15.7
6	60	20.0
10	50	16.7
11	20	6.7

Safety

The vast majority of implants evaluated by MRI showed no evidence of rupture 5 to 11 years after implantation (Table 3). According to the MRI results, five implants showed evidence of rupture, yielding a rupture prevalence of 1.7% at a median implant age of 8 years. There were no indeterminate results, but two scans were unreadable. The five implants classified as ruptured showed an inverted loop on the MRI. Three of the five implants also had subcapsular lines.

Table 3.

Rupture summary (n = 300 implants)

Characteristic	n	%
MRI finding
No evidence of rupture	293	97.7
Evidence of rupture	5	1.7
Indeterminate	0	0
Unreadable	2	0.7
Prevalence of rupture (years)
5	0	0
6	1	2.4
7	1	1.3
8	3	6.3
9	0	0
10	0	0
11	0	0

The length of implantation at the time of rupture diagnosis was 6 years for one implant, 7 years for one implant, and 8 years for three implants. No ruptures were identified 9 to 11 years after implantation.

Of the 300 implants assessed by physical examination at baseline, 298 were not suspected of rupture, and two had no answer. Of the 298 implants not suspected of rupture at baseline, 5 received a diagnosis of rupture by MRI. Thus, all the ruptures were silent and not confirmed by explantation.

Capsular contracture was detected for 5.3% of the implants. All were grade 3, and there were no cases of grade 4 capsular contracture. Asymmetry occurred for 7% of the implants. The vast majority of implants (95%) had no visible creases (wrinkling).

Of the 94 women who attempted breastfeeding before implantation, 36.2% experienced lactation problems. After implantation, 27 women reported attempts to breastfeed, and 22.2% of those experienced a problem. Both before and after implantation, the most common lactation problem was inadequate milk production. Regarding reproduction, 25.8% reported experiencing reproductive problems before receiving their implants, and 8.6% reported problems after implantation. Miscarriage was the most common reproductive problem both before and after implantation, and more than one-third of the women with a postimplantation reproductive problem (35.7%) also had a preimplantation problem. Breast carcinoma was reported for 16% of the subjects before implantation and for 1.8% after implantation.

Effectiveness

Several general quality-of-life measurements showed little change after implantation (Table 4). Physical health, ability to remain active, and working capacity were marked as unchanged by most of the subjects. One general category that did show improvement was overall sense of well-being, which 63% of subjects found to be better.

Table 4.

Subject quality of life

Characteristic	Better (%)a	Unchanged (%)	Worse (%)b
General changes
Physical health	16	78	6
Sense of well-being	63	33	5
Contact with other people	38	59	2
Partner/family life	43	55	3
Remain active	18	76	6
Working capacity	9	86	6
Whole Life	56	40	4
Specific Changes
Body perception	77	18	6
Self-esteem	69	28	4
Ability to exercise	15	75	10
Wearing clothes	72	21	8
Personal charisma	65	31	4
Attraction ability	61	34	4
Intimate experiences	45	46	10
Clothes shopping	64	28	9

^aIncludes responses of “much better,” “quite better,” and “a bit better”

^bIncludes responses of “much worse,” “quite worse,” and “a bit worse”

In contrast, most of the specific measurements showed striking improvement after implantation. Body perception, self-esteem, feeling of wearing clothes, personal charisma, and attraction ability were ranked as better by the majority of women. Clothes shopping was easier for most women, and a large proportion stated that they felt more feminine (Fig. 1). Notably, 91% of the subjects reported that their breast implantation surgery overall was advantageous (Fig. 2). The subject photographs in Fig. 3 provide evidence of the natural aesthetic outcome achieved with Style 410 implantation and how well the results hold up over time.

Fig. 1.

Quality-of-life subject ratings on femininity

Fig. 2.

Quality-of-life subject satisfaction

Fig. 3.

Side and frontal views. a View before implantation. b View 6 months after augmentation with a 395-g Style 410 full-height moderate projection implant. c View 10 years after implantation

Discussion

Our study corroborated on a larger scale the results of the Hedén single-center study because it was performed across multiple European sites and also obtained longer-term data after implantation. Whereas Hedén et al. [1] found a rupture rate of 0.3 to 1.0% at a median implantation time of 6 years in a Swedish cohort of 144 women, our study found a rupture rate of 1.7% at a median implantation time of 8 years. This certainly is consistent with the earlier findings and demonstrates the long-term durability of the Style 410 implant.

An interesting finding in both studies was that no implants were suspected of rupture at physical examination. This finding is consistent with the published literature [3], which demonstrates that physical examination is not a reliable way to diagnose ruptures, and that it may be exacerbated by the more cohesive nature of the gel in the Style 410 implant, resulting in greater difficulty detecting physical signs of rupture. Notably, the MRI rupture signs (e.g., inverted loop, subcapsular line) found in both studies were the same for these highly cohesive implants as those seen on MRIs of ruptured implants with less cohesive silicone gel [4].

Although our study and the earlier Hedén study used the gold standard rupture detection method of MRI, the rupture rates were based on the rupture prevalence at a point in time after implantation, approximately 8 years after implantation in our study. A more accurate depiction of rupture rates is obtained through serial MRIs of the same subjects over time. This method was used in the U.S. pivotal study of the Style 410 shaped gel implants, which found a rupture incidence rate of 0.8% through 3 years after implantation based on MRI screening at years 1 and 3 [5]. This study included 941 augmentation, reconstruction, and revision subjects, approximately one-third of whom participated in the serial MRI component of the study. A third MRI at year 5 for these subjects yielded an implant rupture incidence rate of 3.2% through 5 years [6], slightly higher than that found in our study, but still low.

The 5.3% capsular contracture rate found in our study is consistent with the 5.6% rate found in the study of Hedén et al. [1]. Other researchers also have found little or no capsular contracture using this textured, highly cohesive device. Brown’s series of 150 augmentation and reconstruction patients implanted in Canada with the Style 410 implant had no cases of Baker 3 or 4 capsular contracture during a follow-up period up to 3 years [7]. Similarly, 263 augmentation patients in Brazil also had no Baker 3 or 4 contractures [8]. A prospective study in Spain found no capsular contracture in 45 patients during a 1-year follow-up period [9], and for 25 patients in Switzerland followed 4 to 5 years, no Baker 3 or 4 capsular contracture was found [10]. The prospective U.S. pivotal study reported a 5-year capsular contracture risk rate of 3.3% for augmentation subjects and 9.6% for reconstruction subjects [6]. The low rate of capsular contracture seen with the Style 410 implant across these multiple studies is likely attributable to both the Biocell textured implant surface and the highly cohesive nature of the gel, which applies pressure to the inside of a tight capsule [5, 7].

Our study also demonstrated the low rate of wrinkling for the Style 410 devices, with only 5% of the implants having any visible wrinkles. Long the bane of physicians seeking natural results in the days of saline implants, wrinkles are an uncommon occurrence with the highly cohesive Style 410 implant [7]. This is also borne out in the U.S. pivotal study, which found a wrinkling rate lower than 1% for augmentation subjects and 2.5% for reconstruction subjects through 5 years [6]. The form-stable nature of the Style 410 allows it to maintain its shape and upper pole fill while resisting collapse and folding, thus minimizing the opportunity for wrinkling [7].

As in the study of Hedén et al. [1], quality-of-life measurements showed postimplantation improvements in factors such as body perception, self-esteem, and femininity as well as high rates of subject satisfaction. Whereas other studies have shown satisfaction and psychosocial improvement in the short term after cosmetic augmentation [5, 11, 12]. our study presents these findings from a vantage point of 8 years, on the average, after implantation, pointing to the prolonged stability of the results.

Conclusion

The Style 410 anatomically shaped form-stable gel breast implants have demonstrated long-term safety and effectiveness. Up to 11 years after implantation, the vast majority of subjects were satisfied with their implants, and the complication rates, including rupture, remained low.